Assessment of streptococcus pneumoniae capsule in conjunctivitis and keratitis in vivo neuraminidase activity increases in nonencapsulated pneumococci following conjunctival infection

Current Eye Research

Volumn 35, Issue 9, 2010, Pages 787-798

  Norcross, Erin W ^a   Tullos, Nathan A ^a   Taylor, Sidney D ^a   Sanders, Melissa E ^a   Marquart, Mary E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Capsule; Conjunctivitis; Keratitis; Neuraminidase; Streptococcus pneumoniae

Indexed keywords

SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIUM MUTANT; BACTERIUM TRANSFORMATION; CONJUNCTIVA; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA STROMA; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; KERATITIS; MACROPHAGE; NEUTROPHIL; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; RABBIT; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BACTERIAL CAPSULES; COLONY COUNT, MICROBIAL; CONJUNCTIVITIS, BACTERIAL; DISEASE MODELS, ANIMAL; DNA PRIMERS; GRANULOCYTES; KERATITIS; MACROPHAGES; NEURAMINIDASE; NEUTROPHILS; OLIGONUCLEOTIDES; PNEUMOCOCCAL INFECTIONS; RABBITS; STREPTOCOCCUS PNEUMONIAE;

EID: 77956167217     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2010.492462     Document Type: Article

References (61)

1. Jedrzejas MJ. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev. 2001;65:187-207.
2. Bhave P, Chamie G. Streptococcus pneumoniae keratitis. J Hosp Med. 2008;3:353.
3. Bharathi MJ, Ramakrishnan R, Vasu S, et al. Epidemiology of bacterial keratitis in a referral centre in South India. Indian J Med Microbiol. 2003;21:239-245.
4. Martin M, Turco JH, Zegans ME, et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med. 2003;348:1112-1121.
5. Crum NF, Barrozo CP, Chapman FA, et al. An outbreak of conjunctivitis due to a novel unencapsulated Streptococcus pneumoniae among military trainees. Clin Infect Dis. 2004;39:1148-1154.
6. Buck JM, Lexau C, Shapiro M, et al. A community outbreak of conjunctivitis caused by nontypeable Streptococcus pneumoniae in Minnesota. Pediatr Infect Dis J. 2006;25:906-911.
7. Tarabishy AB, Jeng BH. Bacterial conjunctivitis: A review for internists. Cleve Clin J Med. 2008;75:507-512.
8. Dada T, Sharma N, Dada VK, et al. Pneumococcal kerati-tis after laser in situ keratomileusis. J Cataract Refract Surg. 2000;26:460-461.
9. Jhanji V, Moorthy S, Vajpayee RB. Microbial keratitis in patients with down syndrome: A retrospective study. Cornea. 2009;28:163-165.
10. Holden BA, Sweeney DF, Sankaridurg PR, et al. Microbial keratitis and vision loss with contact lenses. Eye Contact Lens. 2003;29:S131-S134.
11. Saeed A, D'Arcy F, Stack J, et al. Risk factors, microbiological fndings, and clinical outcomes in cases of microbial keratitis admitted to a tertiary referral center in Ireland. Cornea. 2009;28:285-292.
12. Wagoner MD, Al-Ghamdi AH, Al-Rajhi AA. Bacterial keratitis after primary pediatric penetrating keratoplasty. Am J Ophthalmol. 2007;143:1045-1047.
13. Norina TJ, Raihan S, Bakiah S, et al. Microbial keratitis: Aeti-ological diagnosis and clinical features in patients admitted to Hospital Universiti Sains Malaysia. Singapore Med J. 2008;49:67-71.
14. Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbial keratitis in South India: Infuence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14:61-69.
15. Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005;24:823-828.
16. Di BS, Higa M, Janer M, et al. [Neonatal conjunctivitis in a hospital at Gran Buenos Aires. Last 5 years up-date]. Rev Argent Microbiol. 2005;37:139-141.
17. Patel PB, Diaz MC, Bennett JE, et al. Clinical features of bacterial conjunctivitis in children. Acad Emerg Med. 2007;14: 1-5.
18. Epling J. Bacterial conjunctivitis. Clin Evid (Online). 2007.
19. Bodor FF. Conjunctivitis-otitis syndrome. Pediatrics. 1982;69:695-698.
20. Smith AF, Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC Ophthalmol. 2009;9:13
21. Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49:1-35.
22. Hyams C, Camberlein E, Cohen JM, et al. The Streptococcus pneumoniae capsule inhibits complement activity and neu-trophil phagocytosis by multiple mechanisms. Infect Immun. 2010;78:704-715.
23. Li J, Szalai AJ, Hollingshead SK, et al. Antibody to the type 3 capsule facilitates immune adherence of pneumococci to erythrocytes and augments their transfer to macrophages. Infect Immun. 2009;77:464-471.
24. Watson DA, Musher DM. Interruption of capsule production in Streptococcus pneumonia serotype 3 by insertion of transposon Tn916. Infect Immun. 1990;58:3135-3138.
25. Magee AD, Yother J. Requirement for capsule in colonization by Streptococcus pneumoniae. Infect Immun. 2001;69: 3755-3761.
26. Srinivasan M, Gonzales CA, George C, et al. Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India. Br J Ophthalmol. 1997;81:965-971.
27. Reed JM, O'Callaghan RJ, Girgis DO, et al. Ocular virulence of capsule-defcient Streptococcus pneumoniae in a rabbit ker-atitis model. Invest Ophthalmol Vis Sci. 2005;46:604-608.
28. Shayegani M, Parsons LM, Gibbons WE, Jr.,et al. Characterization of nontypeable Streptococcus pneumoniae-like organisms isolated from outbreaks of conjunctivitis. J Clin Microbiol. 1982;16:8-14.
29. Carvalho MG, Steigerwalt AG, Thompson T, et al. Con-frmation of nontypeable Streptococcus pneumoniae-like organisms isolated from outbreaks of epidemic conjunctivitis as Streptococcus pneumoniae. J Clin Microbiol. 2003;41: 4415-4417.
30. Williamson YM, Gowrisankar R, Longo DL, et al. Adherence of nontypeable Streptococcus pneumoniae to human conjunc-tival epithelial cells. Microb Pathog. 2008;44:175-185.
31. Manco S, Hernon F, Yesilkaya H, et al. Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect Immun. 2006;74:4014-4020.
32. Uchiyama S, Carlin AF, Khosravi A, et al. The surface-anchored NanA protein promotes pneumococ-cal brain endothelial cell invasion. J Exp Med. 2009;206: 1845-1852.
33. Gut H, King SJ, Walsh MA. Structural and functional studies of Streptococcus pneumoniae neuraminidase B: An intramolecular trans-sialidase. FEBS Lett. 2008;582:3348-3352.
34. Pettigrew MM, Fennie KP, York MP, et al. Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect Immun. 2006;74:3360-3365.
35. Lock RA, Paton JC, Hansman D. Comparative effcacy of pneumococcal neuraminidase and pneumolysin as immu-nogens protective against Streptococcus pneumoniae. Microb Pathog. 1988;5:461-467.
36. Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44:124-131.
37. Sung CK, Li H, Claverys J P, et al. An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol. 2001;67: 5190-5196.
38. Pozzi G, Masala L, Lannelli F, et al. Competence for genetic transformation in encapsulated strains of Streptococcus pneumoniae: Two allelic variants of the peptide pheromone. J Bacteriol. 1996;178:6087-6090.
39. Johnson MK, Hobden JA, Hagenah M, et al. The role of pneu-molysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res. 1990;9:1107-1114.
40. Kloosterman TG, van der Kooi-Pol MM, Bijlsma JJ, et al. The novel transcriptional regulator SczA mediates protection against Zn2+ stress by activation of the Zn2+-resis-tance gene czcD in Streptococcus pneumoniae. Mol Microbiol. 2007;65:1049-1063.
41. Gupta R, Shah P, Swiatlo E. Differential gene expression in Streptococcus pneumoniae in response to various iron sources. Microb Pathog. 2009;47:101-109.
42. Hammerschmidt S, Wolff S, Hocke A, et al. Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells. Infect Immun. 2005;73: 4653-4667.
43. Green SN, Sanders M, Moore QC, III, et al. Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum. Invest Ophthalmol Vis Sci. 2008;49:290-294.
44. Dajcs JJ, Thibodeaux BA, Girgis DO, et al. Corneal virulence of Staphylococcus aureus in an experimental model of kerati-tis. DNA Cell Biol. 2002;21:375-382.
45. Guzek JP, Cline DJ, Row PK, et al. Rabbit Streptococcus pneu-moniae keratitis model and topical therapy. Invest Ophthalmol Vis Sci. 1998;39:2012-2017.
46. Royle L, Matthews E, Corfeld A, et al. Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj J. 2008;25:763-773.
47. Hyndiuk RA. Experimental Pseudomonas keratitis. Trans Am Ophthalmol Soc. 1981;79:541-624.
48. Aristoteli LP, Willcox MD. The adhesion of Pseudomonas aeruginosa to high molecular weight human tear flm species corresponds to glycoproteins reactive with Sambucus nigra lectin. Exp Eye Res. 2006;83:1146-1153.
49. Rhim AD, Stoykova L, Glick MC, et al. Terminal glycosyla-tion in cystic fbrosis (CF): A review emphasizing the airway epithelial cell. Glycoconj J. 2001;18:649-659.
50. McNamara NA, Andika R, Kwong M, et al. Interaction of Pseudomonas aeruginosa with human tear fuid components. Curr Eye Res. 2005;30:517-525.
51. Hyams C, Yuste J, Bax K, et al. Streptococcus pneumoniae resistance to complement-mediated immunity is dependent on the capsular serotype. Infect Immun. 2010;78:716-725.
52. Medeiros MI, Neme SN, da S P, et al. Streptococcus pneumoniae and Haemophilus infuenzae as etiological agents of conjunctivitis outbreaks in the region of Ribeirao Preto, S P, Brazil. Rev Inst Med Trop Sao Paulo. 1998;40:7-9.
53. Hammerschmidt S. Adherence molecules of pathogenic pneumococci. Curr Opin Microbiol. 2006;9:12-20.
54. Bootsma HJ, Egmont-Petersen M, Hermans PW. Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: Evi-dence for a distinct response to encapsulated strains. Infect Immun. 2007;75:5489-5499.
55. Berry AM, Paton JC. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun. 2000;68:133-140.
56. Papasergi S, Garibaldi M, Tuscano G, et al. Plasminogen-and fbronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells. J Biol Chem. 2010;285:7517-7524.
57. Johnson MK, Hobden JA, O'Callaghan RJ, et al. Confrma-tion of the role of pneumolysin in ocular infections with Streptococcus pneumoniae. Curr Eye Res. 1992;11:1221-1225.
58. Jounblat R, Kadioglu A, Mitchell TJ, et al. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Infect Immun. 2003;71:1813-1819.
59. Paton JC, Rowan-Kelly B, Ferrante A. Activation of human complement by the pneumococcal toxin pneumolysin. Infect Immun. 1984;43:1085-1087.
60. Rubins JB, Charboneau D, Fasching C, et al. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med. 1996;153:1339-1346.
61. Rubins JB, Janoff EN. Pneumolysin: A multifunctional pneu-mococcal virulence factor. J Lab Clin Med. 1998;131:21-27.